Caroline Rivera1, Pierre-Emmanuel Falcoz2, Alain Bernard3, Pascal A Thomas4, Marcel Dahan5. 1. Department of Thoracic Surgery, Haut Lévêque Hospital, University of Bordeaux, Bordeaux. Electronic address: krorivera@yahoo.fr. 2. Department of Thoracic Surgery, Civil Hospital, University of Strasbourg, Strasbourg. 3. Department of Thoracic Surgery, Bocage Hospital, University of Dijon, Dijon. 4. Department of Thoracic Surgery, North Hospital, University of Marseille, Marseille. 5. Department of Thoracic Surgery, Larrey Hospital, University of Toulouse, Toulouse, France.
Abstract
BACKGROUND: The number of oncogeriatric patients with non-small cell lung cancer (NSCLC) is expected to increase in the next decades. METHODS: We used the French Society of Thoracic and Cardiovascular Surgery database Epithor that includes information on > 140,000 procedures from 98 institutions. We prospectively collected data from January 2004 to December 2008 on 1,969 patients aged ≥ 70 years with NSCLC stage I or II and matched them with 1,969 control subjects aged < 70 years for sex, American Society of Anesthesia score, performance status, and FEV(1). Surgical treatment and postoperative outcomes were compared between the two age groups. RESULTS: The absence of radical lymphadenectomy was more frequent in the older patients (14%, n = 269) than in the younger patients (9%, n = 170) (P < .0001). There was no significant difference in type of resection between older and younger patients, respectively (pneumonectomy, 8% [n = 164] vs 11% [n = 216]; lobectomy, 79% [n = 1,559] vs 77% [n = 1,521]; bilobectomy, 4% [n = 88] vs 5% [n = 97]; sublobar resection, 7% [n = 143] vs 6% [n = 118]; P = .08). Differences in number (P = .07) and severity (P = .69) of complications were not significant. Postoperative mortality was higher in elderly patients at every end point (30-day mortality, 3.6% [n = 70] vs 2.2% [n = 43] [P = .01]; 60-day mortality, 4.1% [n = 80] vs 2.4% [n = 47] [P = .003]; 90-day mortality, 4.7% [n = 93] vs 2.5% [n = 50] [P = .0002]). CONCLUSIONS: Elderly patients with NSCLC should not be denied pulmonary resection on the basis of chronologic age alone. Among patients aged ≥ 70 years, 90-day mortality compared acceptably with mortality among younger matched patients. Additionally, the data show that for older patients, a 90-day mortality better represents their real mortality risk than 30- or 60-day figures. Our contemporary, multiinstitutional data importantly reveal that elderly patients, compared with their younger counterparts, do not have increased morbidity, incidence, or severity after pulmonary resection.
BACKGROUND: The number of oncogeriatric patients with non-small cell lung cancer (NSCLC) is expected to increase in the next decades. METHODS: We used the French Society of Thoracic and Cardiovascular Surgery database Epithor that includes information on > 140,000 procedures from 98 institutions. We prospectively collected data from January 2004 to December 2008 on 1,969 patients aged ≥ 70 years with NSCLC stage I or II and matched them with 1,969 control subjects aged < 70 years for sex, American Society of Anesthesia score, performance status, and FEV(1). Surgical treatment and postoperative outcomes were compared between the two age groups. RESULTS: The absence of radical lymphadenectomy was more frequent in the older patients (14%, n = 269) than in the younger patients (9%, n = 170) (P < .0001). There was no significant difference in type of resection between older and younger patients, respectively (pneumonectomy, 8% [n = 164] vs 11% [n = 216]; lobectomy, 79% [n = 1,559] vs 77% [n = 1,521]; bilobectomy, 4% [n = 88] vs 5% [n = 97]; sublobar resection, 7% [n = 143] vs 6% [n = 118]; P = .08). Differences in number (P = .07) and severity (P = .69) of complications were not significant. Postoperative mortality was higher in elderly patients at every end point (30-day mortality, 3.6% [n = 70] vs 2.2% [n = 43] [P = .01]; 60-day mortality, 4.1% [n = 80] vs 2.4% [n = 47] [P = .003]; 90-day mortality, 4.7% [n = 93] vs 2.5% [n = 50] [P = .0002]). CONCLUSIONS: Elderly patients with NSCLC should not be denied pulmonary resection on the basis of chronologic age alone. Among patients aged ≥ 70 years, 90-day mortality compared acceptably with mortality among younger matched patients. Additionally, the data show that for older patients, a 90-day mortality better represents their real mortality risk than 30- or 60-day figures. Our contemporary, multiinstitutional data importantly reveal that elderly patients, compared with their younger counterparts, do not have increased morbidity, incidence, or severity after pulmonary resection.
Authors: Takashi Eguchi; Sarina Bains; Ming-Ching Lee; Kay See Tan; Boris Hristov; Daniel H Buitrago; Manjit S Bains; Robert J Downey; James Huang; James M Isbell; Bernard J Park; Valerie W Rusch; David R Jones; Prasad S Adusumilli Journal: J Clin Oncol Date: 2016-10-31 Impact factor: 44.544
Authors: Chi-Fu Jeffrey Yang; Nicholas R Mayne; Hanghang Wang; Ryan R Meyerhoff; Sameer Hirji; Betty C Tong; Matthew Hartwig; David Harpole; Thomas A D'Amico; Mark Berry Journal: Ann Thorac Surg Date: 2016-05-25 Impact factor: 4.330
Authors: Eric D Brooks; Bing Sun; Lina Zhao; Ritsuko Komaki; Zhonxing Liao; Melenda Jeter; James W Welsh; Michael S O'Reilly; Daniel R Gomez; Stephen M Hahn; John V Heymach; David C Rice; Joe Y Chang Journal: Int J Radiat Oncol Biol Phys Date: 2016-12-21 Impact factor: 7.038
Authors: Filip Kaniski; Lindsey Enewold; Anish Thomas; Shakuntala Malik; Jennifer L Stevens; Linda C Harlan Journal: Lung Cancer Date: 2016-11-29 Impact factor: 5.705
Authors: Gopal C Kowdley; Nishant Merchant; James P Richardson; Justin Somerville; Myriam Gorospe; Steven C Cunningham Journal: ScientificWorldJournal Date: 2012-01-03
Authors: Byungjoon Park; Genehee Lee; Hong Kwan Kim; Yong Soo Choi; Jae Il Zo; Young Mog Shim; Jhingook Kim Journal: World J Surg Oncol Date: 2016-01-19 Impact factor: 2.754